期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 910, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejphar.2021.174492
关键词
CREB; Acetyl CoA; Keap 1; NF-kappa B; Sirtuin; NAD
Fisetin, as a potential molecule for treating neurodegenerative diseases, is believed to positively impact neurobehavioral and cognitive abnormalities. It has shown various health benefits in clinical models of neurodegenerative diseases and is thought to have the potential to treat these diseases through multiple mechanisms.
Neurodegenerative disorders pose a significant health burden and imprint a debilitative impact on the quality of life. Importantly, aging is intricately intertwined with the progression of these disorders, and their prevalence increases with a rise in the aging population worldwide. In recent times, fisetin emerged as one of the potential miracle molecules to address neurobehavioral and cognitive abnormalities. These effects were attributed to its actions on several macromolecules and multiple molecular mechanisms. Fisetin belongs to a class of flavonoids, which is found abundantly in several fruits and vegetables. Fisetin has manifested several health benefits in preclinical models of neurodegenerative diseases such as Alzheimer's disease, Vascular dementia, and Schizophrenia. Parkinson's disease, Amyotrophic Lateral Sclerosis, Huntington's disease, Stroke, Traumatic Brain Injury (TBI), and age-associated changes. This review aimed to evaluate the potential mechanisms and pharmacological effects of fisetin in treating several neurological diseases. This review also provides comprehensive data on up-to-date recent literature and highlights the various mechanistic pathways pertaining to fisetin's neuroprotective role.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据